The European Life Sciences Web Portal
This is a free web portal for the life sciences in Europe and Israel... » read more
- Osthus Partners with Dotmatics to Support Life Sciences R&D (2015-08-24)
Osthus joins forces with Dotmatics The new partnership will allow Osthus to expand its partner portfolio, providing end-users with improved product knowledge in R&D IT environments across life science and other related industries. “Our new alliance will now...
- New NOK1.5 Billion Oslo Cancer Cluster Innovation Park Opens (2015-08-24)
Prime Minister of Norway, Erna Solberg, today opened the Oslo Cancer Cluster Innovation Park. Representing a NOK1.5 billion public-private investment, the Innovation Park brings together the research, healthcare and industry partners in the Oslo oncology value chai...
- AstraZeneca and Peregrine Partner in Immuno-oncology (2015-08-24)
AstraZeneca today announced that it has entered into a clinical trial collaboration with Peregrine Pharmaceuticals, Inc. to evaluate the safety and efficacy of Peregrine’s investigational phosphatidylserine (PS)-signalling pathway inhibitor, bavituximab, in combina...
- AZ Appoints Sean Bohen EVP Global Medicines Development (2015-08-24)
AstraZeneca today announced the appointment of Sean Bohen MD, PhD, as Executive Vice President of Global Medicines Development and Chief Medical Officer. He will join the company on 15 September. Dr. Bohen will be responsible for driving the progress of AstraZen...
- GSK to Divest All Rights to Ofatumumab to Novartis (2015-08-21)
GlaxoSmithKline plc (LSE/NYSE: GSK) today announced an agreement with Novartis Pharma AG (“Novartis Pharma”), a subsidiary of Novartis AG, to divest its rights in ofatumumab for auto-immune indications, including multiple sclerosis. Novartis Pharma previously ac...
- MedImmune Acquires Rights to Inovio’s HPV Cancer Vaccine (2015-08-10)
Agreement includes clinical-stage INO-3112 HPV cancer vaccine and preclinical collaboration to develop additional cancer vaccine candidates AstraZeneca today announced that MedImmune, its global biologics research and development arm, has entered into a license ...
- Novartis Completes Divestiture of Influenza Vaccines to CSL (2015-08-03)
CSL Limited acquired influenza vaccines business of Novartis, including influenza vaccines development pipeline Novartis today announced that it has completed effective July 31, 2015 the divestiture of its influenza vaccine unit to CSL Limited. This marks t...
- Eurofins Closes Majority Acquisition of Bio-Access/Labazur (2015-08-03)
Eurofins Scientific (EUFI.PA), the global leader in bio-analytical testing, and one of the world leaders in genomic services, announces the successful closing of the transaction to acquire a controlling stake in Bio-Access, together with its founder Dr. Jean-Louis ...
- Thomas Bachmann Joins Eppendorf as CEO from Bruker (2015-08-03)
Thomas Bachmann became Chief Executive Officer of the Eppendorf Group on August 1, 2015. Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on...
- Santhera: Capital Increase to Finance LHON Launch of Raxone (2015-07-31)
Santhera Pharmaceuticals (SIX: SANN) announces the intent to sell up to 300,000 registered shares of newly created treasury shares (representing 6.03% of the company's total outstanding share capital). The proceeds will be used to finance the commercial launch of R...
Life-Sciences-Europe.com is your doorway to the European life sciences!
[LSE] provides free, up-to-date and structured access to
in Europe and Israel.
Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!Start here with the latest News!
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to firstname.lastname@example.org and simply fill the subject line with the word »LSE newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]